Literature DB >> 15872362

Correction of photon attenuation and collimator response for a body-contouring SPECT/CT imaging system.

Youngho Seo1, Kenneth H Wong, Mingshan Sun, Benjamin L Franc, Randall A Hawkins, Bruce H Hasegawa.   

Abstract

UNLABELLED: (111)In-Capromab pendetide imaging is indicated for postprostatectomy patients at risk for residual or recurrent disease. However, this study is complicated by relatively long times for tumor uptake and background washout that require imaging to be performed several days after radiopharmaceutical administration. In addition, (111)In-capromab pendetide demonstrates uptake in normal structures that produce images that are interpreted best using correlation with anatomic imaging. Finally, the visual quality of radionuclide imaging can be improved with corrections for photon attenuation and for the geometric response of the radionuclide collimator. Therefore, we have evaluated the advantages of using a commercially available dual-modality SPECT/CT system. In this article, we evaluate a novel iterative reconstruction algorithm using the SPECT/CT data obtained from phantoms and (111)In-capromab pendetide patient studies.
METHODS: Phantom data acquired with the dual-head SPECT camera were reconstructed using both filtered backprojection (FBP) and an iterative maximum-likelihood expectation maximization (MLEM) algorithm incorporating corrections for (a) attenuation coefficient at the effective energy of the radionuclide (either (99m)Tc or (111)In) and (b) collimator response based on experimentally measured depth-dependent spatial resolution of the camera. The collimator response model used the coregistered CT image to estimate the source-target distances produced by the patient-contouring logic of the SPECT camera. Spatial resolution was measured using SPECT images of 2 line sources and uniformity from a uniform cylindric tank. Clinical (111)In-capromab pendetide SPECT/CT data were acquired according to the radiopharmaceutical manufacturer's protocol. Region-of-interest (ROI) analysis of a transverse slice at the level of the sacral base produced mean, median, maximum, and minimum counts per pixel for bone marrow and surrounding soft-tissue ROIs. Ratios of the mean capromab pendetide uptake within marrow to uptake within soft tissue were compared for images reconstructed with FBP versus that obtained from the MLEM method with photon attenuation and collimator response corrections.
RESULTS: The source-target distances reconstructed from the patient-specific CT image agreed well with the corresponding values recorded manually from the camera display unit. This information was incorporated into the iterative reconstruction algorithms and improved the quality of SPECT images from phantoms and patients versus SPECT images reconstructed without the depth-dependent collimator response model. Qualitatively, SPECT images reconstructed with corrections for photon attenuation and collimator response showed less background activity and improved target contrast compared with those images reconstructed with FBP. The target-to-background ratio (marrow uptake-to-soft-tissue uptake) was significantly better using MLEM reconstruction than with FBP when mean uptake values were measured.
CONCLUSION: A priori anatomic data can be used to enhance the quality of the SPECT image when reconstructed using iterative techniques (e.g., MLEM) that use the CT data to produce a patient-specific attenuation map and a collimator response model based on the body contour produced during the SPECT acquisition.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15872362

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  19 in total

Review 1.  SPECT-CT: applications in musculoskeletal radiology.

Authors:  S Saha; C Burke; A Desai; S Vijayanathan; G Gnanasegaran
Journal:  Br J Radiol       Date:  2013-10-04       Impact factor: 3.039

Review 2.  Brain single-photon emission CT physics principles.

Authors:  R Accorsi
Journal:  AJNR Am J Neuroradiol       Date:  2008-06-26       Impact factor: 3.825

Review 3.  Technological development and advances in single-photon emission computed tomography/computed tomography.

Authors:  Youngho Seo; Carina Mari; Bruce H Hasegawa
Journal:  Semin Nucl Med       Date:  2008-05       Impact factor: 4.446

4.  Technical Note: Simplified and practical pretherapy tumor dosimetry - A feasibility study for 131 I-MIBG therapy of neuroblastoma using 124 I-MIBG PET/CT.

Authors:  Youngho Seo; Yoonsuk Huh; Shih-Ying Huang; J Miguel Hernandez-Pampaloni; Randall A Hawkins; W Clay Gustafson; Kieuhoa T Vo; Katherine K Matthay
Journal:  Med Phys       Date:  2019-03-12       Impact factor: 4.071

5.  Combined SPECT and Multidetector CT for Prostate Cancer Evaluations.

Authors:  Carina Mari Aparici; David Carlson; Nhan Nguyen; Randall A Hawkins; Youngho Seo
Journal:  Am J Nucl Med Mol Imaging       Date:  2012

6.  A quantitative index measured on ⁹⁹mTc GSA SPECT/CT 3D fused images to evaluate severe fibrosis in patients with chronic liver disease.

Authors:  Morikatsu Yoshida; Shinya Shiraishi; Fumi Sakaguchi; Daisuke Utsunomiya; Kuniyuki Tashiro; Seiji Tomiguchi; Hirohisa Okabe; Toru Beppu; Hideo Baba; Yasuyuki Yamashita
Journal:  Jpn J Radiol       Date:  2012-04-12       Impact factor: 2.374

7.  In vivo tumor grading of prostate cancer using quantitative 111In-capromab pendetide SPECT/CT.

Authors:  Youngho Seo; Carina Mari Aparici; Matthew R Cooperberg; Badrinath R Konety; Randall A Hawkins
Journal:  J Nucl Med       Date:  2009-12-15       Impact factor: 10.057

Review 8.  Functional imaging for prostate cancer: therapeutic implications.

Authors:  Carina Mari Aparici; Youngho Seo
Journal:  Semin Nucl Med       Date:  2012-09       Impact factor: 4.446

Review 9.  Morphology supporting function: attenuation correction for SPECT/CT, PET/CT, and PET/MR imaging.

Authors:  Tzu C Lee; Adam M Alessio; Robert M Miyaoka; Paul E Kinahan
Journal:  Q J Nucl Med Mol Imaging       Date:  2015-11-17       Impact factor: 2.346

10.  Biodistributions of 177Lu- and 111In-labeled 7E11 antibodies to prostate-specific membrane antigen in xenograft model of prostate cancer and potential use of 111In-7E11 as a pre-therapeutic agent for 177Lu-7E11 radioimmunotherapy.

Authors:  Mei-Hsiu Pan; Dong-Wei Gao; Jinjin Feng; Jiang He; Youngho Seo; John Tedesco; John G Wolodzko; Bruce H Hasegawa; Benjamin L Franc
Journal:  Mol Imaging Biol       Date:  2008-11-25       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.